Cassava Sciences | PTIE - Assets

Stock Price
1.95
Daily Change
-0.02 -1.02%
Monthly
-7.14%
Yearly
-20.08%
Q1 Forecast
1.93

Cassava Sciences reported $129.73M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Abbott USD 84.18B 182M Sep/2025
Amgen USD 90.14B 2.24B Sep/2025
Biogen USD 29.21B 877.3M Sep/2025
Cassava Sciences USD 129.73M 5.65M Sep/2025
Eisai JPY 1.44T 28.38B Sep/2025
Eli Lilly USD 114.94B 14.01B Sep/2025
Geron USD 567.38M 12.18M Sep/2025
J&J USD 192.82B 573M Sep/2025
Merck USD 129.55B 12.02B Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025